Lixte Biotechnology Holdings Inc. (LIXT)
NASDAQ · Healthcare
Lixte Biotechnology Holdings Inc. annual/quarterly total liabilities history from 2010 to 2015. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Lixte Biotechnology Holdings Inc. total liabilities for the quarter ending December 31, 2015 were 285,642, a 11.23% decrease year-over-year.
- Lixte Biotechnology Holdings Inc. total liabilities for 2015 were 285,642, a 11.23% decrease from 2013.
- Lixte Biotechnology Holdings Inc. total liabilities for 2013 were 321,774, a 23.21% increase from 2012.
- Lixte Biotechnology Holdings Inc. total liabilities for 2012 were 261,152, a 25.54% decrease from 2011.
- Lixte Biotechnology Holdings Inc. total liabilities for 2011 were 350,746.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Lixte Biotechnology Holdings Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2015 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| Lixte Biotechnology Holdings Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2015-12-31 | $0 |
| 2013-12-31 | $0 |
| 2012-12-31 | $0 |
| 2011-12-31 | $0 |
| 2010-12-31 | $0 |
Lixte Biotechnology Holdings Inc. Total Liabilities — FAQ
Lixte Biotechnology Holdings Inc. (LIXT) total liabilities over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LIXT's total liabilities history?
The chart and table above show Lixte Biotechnology Holdings Inc.'s total liabilities by year and by quarter, including the growth rate.